MicroRNA-targeting therapeutics for hepatitis C

Global control of hepatitis C: where challenge meets opportunity

(2013) David L Thomas   NATURE MEDICINE

Current and Future Therapies for Hepatitis C Virus Infection

(2013) T. Jake Liang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of HCV Infection by Targeting MicroRNA

(2013) Harry L.A. Janssen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Discovering the first microRNA-targeted drug

(2012) Morten Lindow et al.   JOURNAL OF CELL BIOLOGY

Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis

(2012) Wei Nie et al.   PLoS One

New treatments for chronic hepatitis C virus infection

(2011) M. Corouge et al.   MEDECINE ET MALADIES INFECTIEUSES

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

(2011) Kenneth E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Small Molecule Modifiers of MicroRNA miR-122 Function for the Treatment of Hepatitis C Virus Infection and Hepatocellular Carcinoma

(2010) Douglas D. Young et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Evaluation of VCH-759 monotherapy in hepatitis C infection

(2009) Curtis Cooper et al.   JOURNAL OF HEPATOLOGY

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

Regulation of hepatitis C virus by microRNA-122: Figure 1

(2008) Catherine L. Jopling   BIOCHEMICAL SOCIETY TRANSACTIONS

LNA-mediated microRNA silencing in non-human primates

(2008) Joacim Elmén et al.   NATURE